UNSPSC 51422301: Alclometasone

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 136H45TB7B. European Medicines Agency schedules Alclometasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05300MIG. Alclometasone generally arises in the molecular formula C22H29CLO5.

UNSPSC 51422301 Alclometasone, a Commodity code, does not align with the recent state and local procurement activity posted under it. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, a procurement focused on opioid-overdose response and harm-reduction supplies rather than the steroid medication the code nominally describes. The mismatch between code assignment and actual scope indicates that this Commodity code shows little relevant recent activity in state and local procurement.

The single recent opportunity on file—Seminole County's naloxone and drug deactivation systems IFB with a July 26, 2023 response deadline—does not represent typical activity under the code. Vendors responding to such miscoded solicitations should verify the actual commodity or service before pursuing, as the UNSPSC classification may not reflect the goods being purchased.